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Somatostatin-like immunoreactivity in the glomerulus of rat kidney. It
has been shown that somatostatin inhibits the antidiuretic action of
vasopressin in toad urinary bladder in vitro and in dogs and rats in vivo.
The presence of somatostatin-like immunoreactivity (SLI) in the uri-
nary bladder and kidney of the toad has suggested the possibility that
somatostatin may act as a local paracrine hormone modulating the
effect of vasopressin in the toad; however, the inability to localize SLI
in mammalian kidney has raised doubt about the physiological role of
somatostatin in the mammalian renal function. We identified SLI in rat
kidney. Chromatography of rat kidney extracts of Sephadex G5O
superfine revealed a single peak of SLI that co-eluted with somato-
statin-l4. Using the avidin-biotin-peroxidase conjugate technique, we
localized SLI exclusively to small cells in the glomerulus with an
estimated number of four to eight cells per glomerulus. Functional
significance of somatostatin in the mammalian kidney is to be
determined.
tmmunoréactivité de type somatostatine dans le glomérule de rein de
rat. II a été montre que Ia somatostatine inhibe l'action anti-diurétique
de la vasopressine dans Ia vessie de crapaud in-vitro, et chez des chiens
et des rats in-viva. La presence d'une imrnunoreactivité de type
somatostatine (SLI) dans Ia vessie et le rein du crapaud a suggeré Ia
possibilité que Ia somatostatine pourrait agir comme une hormone
paracrine locale modulant !'effet de Ia vasopressine chez le crapaud;
néanmoins, l'impossibilite de localiser Ia SLI dans le rein de mammifère
a remis en question le role physiologique de Ia somatostatine dans Ia
fonction du rein de mammifère. Nous avons identiflé une SLI dans Ic
rein de rat. La chromatographie d'extraits de reins de rats sur un
Sephadex G50 très fin a révélé un pie unique de SLI qui co-migrait avec
Ia somatostatine-14. En utilisant une technique par un conjugué avidine-
biotine peroxidase, nous avons localisé le SLI exclusivement dans de
petites cellules du glomerule, avec un nombre estimé de quatre a huit
cellules par glomérule. La signification fonctionnelle de Ia somatosta-
tine dans Ic rein de mammifère reste a determiner.
Somatostatin, a tetradecapeptide initially isolated from ovine
hypothalamus [1], has been localized by immunochemical tech-
niques to a variety of other tissues [2]. Although somatostatin-
like immunoreactivity (SLI) has been described in urinary
bladder and kidney of the toad [3, 4], its presence has not been
clearly established in mammalian kidney [3, 5—7]. Somatostatin
has been shown to modulate the release and action of a variety
of hormones and exocrine secretions [2]. In the kidney, somato-
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statin has been shown to inhibit vasopressin-induced antidiure-
sis [8—10]; thus, it may play a physiological role in the regulation
of renal function. In the present communication, we report that
SLI is present in the mammalian kidney and that SLI-contain-
ing cells are localized to the glomerulus.
Methods
Male Sprague-Dawley rats (200 to 300 g) were anesthetized
with ether, and their kidneys were perfused in situ with Krebs-
Ringer bicarbonate buffer, pH 7.4, equilibrated with 95% 02/5%
CO2. Kidneys were removed rapidly, extracted in 10 ml of 3%
acetic acid per gram of wet weight [11], and the extracts were
concentrated to 1 ml by vacuum centrifugation. The concentrat-
ed extracts were quantified for SLI by radioimmunoassay with
antibody 1001 as previously described [11, 12]. The minimum
detection limit for radioimmunoassay was 1.3 fmoles/ml with
inter- and intra-assay coefficients of variation equal to 13 and
8%, respectively. Antibody 1001 is specific for the ring portion
of somatostatin and cross-reacts approximately 50% with soma-
tostatin-28 [12]. To further characterize the nature of SLI,
extracts of kidneys from 60 rats were concentrated, then
applied to a Sephadex G-50 (superfine) column (1 x 120 cm) and
eluted with 0.1 M ammonium acetate, pH 5.0. Each fraction (2.0
ml) was measured for SLI by radioimmunoassay. The SLI
content of rat kidney was also determined under several meta-
bolic perturbations. They include water loading, dehydration,
saline in drinking water, and vitamin D deficiency, as specified
below.
The localization of SLI in the kidney was determined using
the avidin-biotin-peroxidase complex technique [131. Freshly
removed rat kidneys were immersion-fixed in Bouin's solution
for 48 hr, dehydrated, and embedded in Paraplast. Several 4-sm
sections of the kidney fixed with Bouin's solution were incubat-
ed for 30 mm with sheep antisomatostatin antibody 8093 at a
dilution of 1:700 followed by 30 mm incubation with biotin-
conjugated rabbit anti-sheep antiserum (Vector Laboratories,
Burlingame, California) as second antibody. The sections were
then incubated with avidin-biotin-peroxidase complex and 3,3'-
diaminobenzidine HC1 was used as chromogen. All sections
were pre-incubated with avidin, biotin, and nonimmune rabbit
serum to eliminate nonspecific staining. Antibody 8093 has
identical specificity as antibody 1001 but is less sensitive when
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Fig. 1. Standard curve for radioimmunoassay of somatostatin-like
immunoreactivity (SL1). Dilutions of two representative kidney ex-
tracts (0, ), displaced the binding of 1251-Tyr'-somatostatin from
antisomatostatin antibody in parallel with the standard curve obtained
with synthetic somatostatin tetradecapeptide (•).
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Fig. 2. Chromatographic elution of somatostatin-like immunoreactivity
(SLI) in 3% acetic acid extracts of rat kidney. The extracts were applied
to a Sephadex G 50 (superfine) column (I x 120 cm) and eluted with 0.1
M ammonium acetate, pH 5.0. Each fraction (2.0 ml) was measured for
SLI by radioimmunoassay. The column was calibrated by the elution of
bovine serum albumin (V0), NaCl (V3, and somatostatin 14 (S14).
Results and Discussion
Using radioimmunoassay we found SLI in rat kidney. The
content of the SLI was 0.36 + 0.05(sE) pmoles/kidney (N =6).
Dilution of kidney extracts paralleled the standard curve for
radioimmunoassay obtained with synthetic somatostatin tetra-
decapaptide (Fig. 1). The nature of SLI was further character-
ized by column chromatography. As shown in Figure 2 SLI
appeared as a single peak which co-eluted with synthetic
somatostatin (Peninsula Laboratories, Belmont, California),
suggesting that the SLI measured in the kidney was similar to
somatostatin- 14.
As shown in Table 1, there were no significant changes in the
SLI content of rat kidney in response to water loading, dehy-
dration, the addition of 0.9% NaCI in drinking water, and
hypocalcemia secondary to vitamin D deficiency. These data do
not exclude possible alterations in the rate of biosynthesis
and/or release of somatostatin, however.
Previous studies have shown that somatostatin inhibits the
action of vasopressin in the kidney as well as in the toad urinary
bladder [3, 41. Moreover, immunohistochemical studies in the
toad have shown that somatostatin is present in the epithelia of
the urinary bladder and the distal and collecting tubules of the
kidney, suggesting that somatostatin may act as a paracrine
agent modulating the action of vasopressin locally [3, 4]. Since
there was no detectable SLI in the mammalian kidney in
previous studies, the hypothetical role of somatostatin as a local
regulator in mammalian renal function was not investigated
further. Although we were unable to measure SLI with certain-
ty in unmodified kidney extracts, we were able to confirm the
presence of SLI by concentration of samples and show that it
had chemical characteristics similar to somatostatin tetradeca-
peptide. The source of renal SLI is not likely to be from
Table 1. Content of somatostatin-like immunoreactivity (SLI) in rat
kidneya
N SLI, pmoleslkidney
Overnight fast (control) 5 0.36 0.05
Water loading" 6 0.41 0.05
Dehydrationc 6 0.37 0.04
Salt loading" 6 0.34 0.03
Vitamin D deficiency 4 0.25 0.05
Ad lib fed 6 0.26 0.02
Results are expressed as mean SE with the number (N) of rats in
each group. From each rat, both kidneys were combined and extracted
together.
b Drinking water was withheld for 24 hr.
Distilled water (10% body weight) was administered intraperitoneal-
ly 3 hr prior to sacrifice.
' NaCI (0.9%) was provided as drinking water for 24 hr prior to
sacrifice.
Rats were fed a vitamin D deficient diet for 4 to 5 weeks prior to
sacrifice. Animals were fasted overnight in all groups except the last.
contamination with circulating SLI because the concentration
per gram is roughly tenfold of that observed in rat plasma.
Nonetheless, we felt it would be of critical importance to
determine the intra-renal localization of SLI.
As shown in Figure 3, cells containing SLI were localized
exclusively in the glomerulus. The cells appeared to be small
(less than 8 m in diameter) and contained cytoplasmic exten-
sions as described in D-cells of the gut [15]. In 4-tm sections,
we observed only one SLI-positive cell for every five to ten
glomeruli. Rarely we observed a glomerulus with two SLI-
positive cells (Figure 3A). All of the staining was abolished
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used in radioimmunoassay although superior for use in immuno-
histochemistry [14].
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diameter of rat glomeruli (average, 135 .tm [16]), we estimate
that there are four to eight SLI-positive cells per glomerulus.
The glomerulus consists of three major cell types; epithelium,
endothelium, and mesangium. Another cell type which is char-
acterized by cytoplasmic granules and located at a "peripolar"
site adjacent to the juxtaglomerular apparatus has been report-
ed by Ryan, Cochlan, and Scoggins [17]. SLI-containing cells,
because of their location and morphology, do not seem to fit
any of these known cell types in the glomerulus; thus, they may
be prototypical of a new class of glomerular cells requiring
further characterization. Localization of SLI-containing cells to
the glomerulus renders unlikely the possibility that somato-
statin acts on the collecting tubules as a local paracrine agent
modulating the antidiuretic action of vasopressin in the mam-
malian kidney. However, since the blood flow to the tubules
first traverses the glomerulus, it is possible that somatostatin
acts on the tubules through a local portal circuit.
The biological and physiological significance of somatostatin
in the glomerulus is not clear at present. The glomerulus is
capable of producing hormones such as prostaglandins and
angiotensin II which, in turn, have been shown to have pro-
found effects on glomerular and tubular function [18]. Addition-
ally, peptides and amines in circulation are known to affect
glomerular ultrafiltration [181. Since somatostatin has been
shown to modulate the synthesis, release, and action of hor-
mones in other organs [2], it is possible that somatostatin
regulates renal function via a similar mechanism. These possi-
bilities are currently under investigation.
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Fig. 3. Sections of rat kidney stained for SLI using the avidin-biotin-
peroxidase complex technique. A Two darkly stained SLI-containing
cells entirely enclosed within the margins of a single glomerulus. (x308)
B Larger magnification of a single SLI-containing cell within a glomer-
ulus. (x792) The open arrow indicates the margins of Bowman's
capsule. A slightly pale nucleus is surrounded by darkly staining
cytoplasm. Two projections can be seen to extend from the center of
the cell (closed arrows).
when antisomatostatin antiserum was preabsorbed with 30
pmoles/ml of synthetic somatostatin, suggesting that staining
was specific. Given the number of glomenili containing SLI-
positive cells per section and knowing the number and average
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